$OMQS

OMNIQ Corp. Issues Second Quarter 2026 Shareholder Letter and Reports Financial Results

OMNIQ Corp. (OMQS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 OMNIQ Corp. Issues Second Quarter 2026 Shareholder Letter and Reports Financial Results SALT LAKE CITY, Aug. 18, 2026 (GLOBE NEWSWIRE) -- OMNIQ CORP. (OTCQB: OMQS) ("OMNIQ" or the "Company"), a leading provider of AI-based computer vision solutions, reports that incr

Original reporting
Published Aug 18, 2026, 8:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$OMQS
Neutral
low confidence
Mentioned
$OMQS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OMQSNeutralLow
01

Why it matters

The filing itself is a procedural disclosure; the trading-relevant content would be the specific financial results and any outlook contained in Exhibit 99.1, which is not included in the scraped text.

02

Market read

This provides confirmation that results were released the same day, but the provided text lacks the numbers needed to assess impact.

03

What to watch

Traders should verify whether Exhibit 99.1 includes guidance changes, liquidity/covenant updates, or one-time items that could materially shift valuation.

Relevance 7/10Novelty 2/10Timing: filed Aug. 18, 2026, with results press release attached as Exhibit 99.1

Background

The article is an SEC Form 8-K (Item 2.02) indicating OMNIQ Corp. issued a press release with results of operations and financial condition on Aug. 18, 2026.

Company-level read

Ticker impact

$OMQSNeutralLow confidence
Context

OMNIQ Corp. filed an 8-K stating it issued a press release with its results of operations and financial condition on Aug. 18, 2026.

Expected impact

Near-term impact is likely limited until the attached Exhibit 99.1 press release details (numbers, changes, outlook) are reviewed.

Evidence & confidence

The body only confirms the existence of a results press release (Exhibit 99.1) without providing any financial metrics, revisions, or forward-looking statements.

Market effects

No sector-level implications are stated in the provided text.

No regional impact is stated in the provided text.

No global impact is stated in the provided text.

Counterpoint

Because the scraped content omits the actual results, the market reaction may be driven by details in Exhibit 99.1 rather than the filing itself.

Key entities

  • OMNIQ Corp.

    OTC-listed company filing an 8-K for results of operations and financial condition (Item 2.02).

  • SEC Form 8-K

    Current report used to disclose material events; here it references a results press release as Exhibit 99.1.

Related articles

$EXPDMed

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD): Results of Operations and Financial Condition

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 EARNINGS RELEASE By: Expeditors International of Washington, Inc. 3545 Factoria Blvd. SE Sterling Plaza 2, 3rd Floor Bellevue, Washington 98006 CONTACTS : Daniel R. Wall David A. Hackett Geoffrey Buscher President and Chief Executive Officer Senior Vice President and

$MRKMedAI 8/10

Merck’s Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue.

Merck (MRK) reported its sixth consecutive earnings beat, with Q3 adjusted EPS of $2.49 and revenue of $18.09B, exceeding estimates. The company raised its 2026 profit outlook. 24/7 Wall St. set a price target of $124.70, suggesting 15.67% downside from the current price of $147.87, with a hold rating. Merck's pipeline, including Keytruda and sac-TMT, is seen as a potential growth driver, but valuation concerns and generic pressures are noted.

Med

Canton-based Metallus shares profitable third-quarter results

Metallus reported a Q3 2026 profit of $23.8M ($0.55 per share), up from Q2 2026 ($8.9M) and Q3 2025 ($8.1M). Net sales were $337.2M, down 1% sequentially but up 10% year-over-year. The company invested $13.1M in capital and $3.6M in share repurchases, with cash reserves of $98.6M. CEO Mike Williams retired, succeeded by Kristopher Westbrooks, who forecasted favorable market conditions.

$OMedAI 8/10

Realty Income Doubles Down With a Massive $10 Billion Bet

Realty Income (O) raised its 2026 AFFO guidance to $4.45-$4.46 per share and plans to deploy $10B in capital this year. Q3 AFFO was $1.12 per share, up 3.7% YoY. The company invested $2.6B, including $940M in Europe, and sourced $59B in potential investments. It also completed $527M in dispositions and issued $1.6B in notes.

$ITMed

Gartner, Inc. Q3 2026 Earnings Call Summary

Gartner, Inc. reported Q3 2026 earnings, highlighting accelerated contract value growth, improved client retention, and a shift in AI demand. The company raised full-year guidance, anticipating continued growth. Challenges include Middle East conflict impacts and macroeconomic budget cycles. Share repurchases and strategic M&A are key capital allocation focuses.